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Available online 26 February 2016The heterotrimeric CCAAT-binding factor NF-Y controls the expression of a multitude of genes involved in cell
cycle progression. NF-YA is present in two alternatively spliced isoforms, NF-YAs and NF-YAl, differing in 28
aminoacids in the N-terminal Q-rich activation domain. NF-YAs has been identiﬁed as a regulator of stemness
and proliferation in mouse embryonic cells (mESCs) and human hematopoietic stem cells (hHSCs), whereas
the role of NF-YAl is not clear. In themuscle system, NF-YA expression is observed in proliferating cells, but barely
detectable in terminally differentiated cells in vitro and adult skeletal muscle in vivo. Here, we show that NF-YA
inactivation in mouse myoblasts impairs both proliferation and differentiation. The overexpression of the two
NF-YA isoforms differentially affects myoblasts fate: NF-YAs enhance cell proliferation, while NF-YAl boosts dif-
ferentiation. The molecular mechanisms were investigated by expression proﬁlings, detailing the opposite pro-
grams of the two isoforms. Bioinformatic analysis of the regulated promoters failed to detect a signiﬁcant
presence of CCAAT boxes in the regulated genes. NF-YAl activates directly Mef2D, Six genes, and p57kip2
(Cdkn1c), and indirectly the myogenic regulatory factors (MRFs). Speciﬁcally, Cdkn1c activation is induced by
NF-Y binding to its CCAAT promoter and by reducing the expression of the lncRNAKcnq1ot1, a negative regulator
of Cdkn1c transcription. Overall, our results indicate that NF-YA alternative splicing is an inﬂuential muscle cell
determinant, through direct regulation of selected cell cycle blocking genes, and, directly and indirectly, of
muscle-speciﬁc transcription factors.







Skeletal myogenesis, i.e. the formation of skeletal muscle, depends
on multiple myogenic regulatory factors, in particular sequence-
speciﬁc transcription factors, some of which are important for muscle
fate commitment; others are involved in terminal differentiation. Dur-
ing development, the coordinated activity of combinatorial transcrip-
tion factors is fundamental to elicit the proper spatio-temporal
expression of genes throughout the complex process of myogenesis [1,
2]. The family of myogenic regulatory factors (MRFs), composed by
MyoD, Myf5, Myogenin, andMrf4, has a crucial role inmuscle cell spec-
iﬁcation and differentiation [3]. Other transcription factors cooperate
with MRF proteins in regulating target gene expression, such as Mef2
[4] and Six family members [5]. In vertebrates, the Mef2 family consistsouse embryonic stem cells; s.d.,
linari), cimbriano@unimo.it
. This is an open access article underof four proteins (Mef2A-D), all of which act as key players in the activa-
tion of the differentiation program [6]. The mammalian Six family is
composed by six sequence-speciﬁc members (Six1–6), which have an
important role in controlling the development of various organs and tis-
sues [7]. In particular, Six1 and Six4 are involved in skeletal muscle de-
velopment through direct and indirect transcriptional regulation of
myogenic genes, such as Myog, Myf5, Pax3, MyoD, and Pbx [5,8–10].
Skeletal muscle differentiation is strictly associated to cell cycle exit,
orchestrated by cyclin-dependent kinase inhibitors (CDKIs) belonging
to the CIP/Kip family: p21cip1/waf1, p27kip1, and p57kip2, encoded by
Cdkn1a, Cdkn1b, and Cdkn1c genes, respectively. These CDKIs inhibit
cyclin-CDK complexes modulating the activities of cyclin D-, E-, A-,
and B-CDK complexes [11]. p21cip1/waf1 and p57kip2 control differentia-
tion of skeletal muscle and their loss severely affects ﬁber formation:
they have a key role not only in inducing cell cycle exit but also in trig-
gering a muscle-speciﬁc transcriptional program [12]. MyoD transcrip-
tionally controls both Cdkn1a and Cdkn1c expression [13–15]. The
Cdkn1c gene is regulated by MyoD through indirect mechanisms,
consisting in the up-regulation of the intermediate factors p73, Sp1,
and Egr1, and directly by interacting with a distant cis-element locatedthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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downstream of Cdkn1c [14,16,17]. KvDMR1, which is located within in-
tron 10 of the Kcnq1 gene and surrounds the promoter that drives for
non-coding antisense transcript Kcnq1ot1, plays a role in the allele-
speciﬁc expression pattern of different ﬂanking genes belonging to the
same imprinted cluster, composed by Cdkn1C, Kcnq1, Ascl2, Tssc4,
Tssc3, and Slc22a11 [18]. The Kcnq1ot1 promoter is characterized by
multiple CCAAT elements, required for its activity and bound by the
NF-Y complex [19,20].
The transcription factor NF-Y, composed by NF-YA, NF-YB, and NF-YC
subunits, plays a key role in cell proliferation and differentiation. NF-YA
mediates sequence-speciﬁc CCAAT-binding [21]; it is regulated during
cell cycle progression [22] and down-regulated in some cell types under-
going terminal differentiation, including C2C12myoblasts [23–25]. NF-YA
is not expressed in adult muscle tissues and consequently, NF-Y binding
activity to CCAAT boxes is lost in skeletalmuscle and heart [26]. However,
NF-YA is detected in muscle of mdx mice, an animal model for human
Duchenne and Becker muscular dystrophy [27]. In these mice, skeletal
muscle undergoes cycles of degeneration and regeneration, associated
to robust proliferation of satellite cells (SCs) [28]. In addition, the develop-
ment of a transgenicmousemodel harboring aNF-Y-dependent Cyclin B2
promoter driving a luciferase reporter, linked NF-Y activity in living or-
ganisms tomuscle regeneration following acute hind limb ischemia, a re-
pair process carried out by SCs [29,30].
These data support previous evidence showing amajor role of NF-YA
regulation in stem cell biology, through the transcriptional activation of
“stemness” pathways [31–34]. The NF-YA gene encodes two spliced
transcripts, NF-YAl (long) and NF-YAs (short), which differ by retention
of exon 3, coding for 28 aminoacids in the N-terminal Q-rich activation
domain. In transcriptional activation experiments, the two isoforms
showed similar activation potential [35–37], hence they were long
thought to be functionally equivalent. However, NF-YAs transcript is
highly expressed in hematopoietic stem cells (HSCs), decliningwith dif-
ferentiation [34]. Its overexpression in HSCs enhances self-renewal [33],
improving bone marrow transplantations ex vivo. In mouse ES cells
(mES), a switch between NF-YAs and NF-YAl occurs upon differentia-
tion [31,33]: NF-YAs maintains stemness by direct transcriptional acti-
vation of key stem cells genes and by helping core stem transcription
factors to their target genes [31,33]. Differently, the speciﬁc role of NF-
YAl remains elusive.
In this study, we evaluated the activity of the two NF-YA splice var-
iants on proliferation and differentiation of skeletal muscle cells. Over-
all, our data highlight for the ﬁrst time the differential role of NF-YA
isoforms in modulating the myogenic gene expression program.
2. Materials and methods
2.1. Cell line and cultures
C2C12 myoblasts were maintained in Dulbecco's Modiﬁed Eagle's
Medium (DMEM), supplemented with 10% fetal calf serum (GM =
growth medium), avoiding cells becoming N70% conﬂuent. To allow
myoblasts differentiation, cells were grown to complete conﬂuence
and then the medium was switched to DMEM containing 2% horse
serum (DM = differentiation medium). Stable-expressing NF-YA cells
were obtained by lentiviral infection of C2C12 cells with pSIN-NF-YAs
or pSIN-NF-YAl particles for 48 h. Infected cells were then selected
using puromycin (3 μg/ml) and maintained in medium supplemented
with puromycin (1 μg/ml)
2.2. Plasmids
The cDNAof NF-YAs andNF-YAlwere cloned via EcoRI and BglII sites
into EcoRI and BamHI pSIN-EF2-Pur vector backbone. The resulting con-
structs were then sequenced and used to obtain stable NF-YA-
overexpressing cell lines. For transient transfections, pSG5 NF-YAs andNF-YAl plasmids were cotransfected together with pGL3 basic human
Kcnq1ot1 luciferase vector (kindly provided by P.D. Sadowski, Universi-
ty of Toronto) [19] and pGL3 basic human Ckdn1c luciferase vector
(kindly provided by L. Guerrini, University of Milan) [38].
2.3. Transfection
Experiments were performed in triplicate in NIH3T3 cells. For each
point, 100.000 cells were seeded in 24-well plates and transfected
after 24 h with a Metafectene Pro reagent (Biontex) with 100 ng of
pCMV β-Galactosidase and 200 ng of luciferase constructs. Cells were
harvested 48 h post-transfection and resuspended in lysis buffer (1%
Triton X-100, 25 mM glycil-glycine, 15mMMgSO4, 4 mM EGTA) for lu-
ciferase activities. β-Galactosidase was assayed to control transfection
efﬁciency.
2.4. Lentivirus transduction
Lentiviral supernatant expressing empty vector, NF-YAs and NF-YAl
were prepared by transfecting HEK293T packaging cells as previously
described [39]. Brieﬂy, pSIN vector plasmids (20 μg) and second-gener-
ation packaging plasmids (5 μg of pMD2-VSVG and 15 μg of pCMV-
dR8.74) were cotransfected into HEK293T cells. Lentivirus-containing
supernatant was collected 24 h after transfection, centrifuged at
3000 rpm to remove cell debris for 5 min, 0.45 μm ﬁltered and frozen
at−80 °C until use. Viral stock solutions were titered by puromycin se-
lection and colony counting.
2.5. RNA interference
Third-generation short hairpin RNA pEGFP-C-sh Lenti scrambled
(TR30021), murine shRNA NF-YA, targeting 5′UTR (AGCTTCAGGACTCT
TAACGTGGCCG) were purchased by Origene. Lentiviral production
was prepared as described for pSIN-NF-YA vectors. The supernatants
were collected after 48 h from the transfection, 0.45 μm-ﬁltered,
ultracentrifugated at 19,000 rpm for 2 h and 30 min and frozen at
−80 °C in medium without serum. Virus titer was determined by
counting of GFP-positive cells. 7000 C2C12 cells/well (35 mm) were
plated and infected by double spinoculation (1800 rpm for 45 min at
30 °C) at MOI 100 and MOI 50. Cells were then harvested for cell cycle
analysis, total extracts and RNA extraction, 72 h after the second infec-
tion. For the analysis of cellular differentiation, 50,000 cells/well
(35 mm) were infected as above, and after 72 h from the second infec-
tion were induced to differentiate in DMmedium for additional 3 days.
2.6. Cytoﬂuorimetric cell cycle analysis
Monoparametric DNA distribution analysis of C2C12 cells was per-
formed by Propidium–Iodide (PI) staining for ﬂow cytometry (Epics
cytoﬂuorimeter, Beckman Coulter).
DNA content was analyzed using bivariate ﬂow cytometry, as previ-
ously described [39]. BrdUpulsed cellswere incubatedwithmouse anti-
BrdU antibody (#317902 BioLegend) for 1 h at 4 °C, and then with FITC
anti-mouse (#F0313 Dako) for 1 h at 4 °C. Cells were then counter-
stained with PI-solution (Propidium–Iodide 25 μg/ml, Na-Citrate
3.4 mM, NaCl 9.65 mM, NP-40 0.03%) for 15 min and analyzed by
cytoﬂuorimeter.
2.7. Proliferation assay
Cell proliferation of stably infected C2C12 cells was assessed by col-
orimetric MTT assay. Brieﬂy, stable-expressing NF-YA cells were seeded
into 24-well plates at a density of 1 × 105 perwell. Four plates were pre-
pared in order to evaluate proliferation at 24, 48, 72, and 96 h. MTT so-
lution (5mg/ml Thiazolyl Blue Tetrazolium Bromide in PBS) was added
to eachwell at a ﬁnal concentration of 0.5mg/ml perwell and the plates
Fig. 1. NF-YA transcriptional modulation during differentiation of C2C12 cells. A. Analysis of NF-YA, NF-YB, Myf5, MyoD, Myogenin (Myog), MyHCII protein levels in C2C12 myoblasts
maintained in growth medium (GM) and induced to differentiate for 0, 2, 4, and 6 days in differentiation medium (DM). HCT116 cell extract was used as a control of NF-YAs
molecular weight. For NF-YA, two blots with different amounts of protein extracts and different exposure time are shown. Vinculin was used as loading control. B. Polyacrilamide gel
electrophoresis of semiquantitative RT-PCR products obtained by ampliﬁcation with primers common to NF-YAs and NF-YAl transcripts in C2C12 myoblasts (Mb). The relative
abundance of NF-YAl versus NF-YAs, performed by absolute quantiﬁcation in qRT-PCR with isoform speciﬁc primers, is indicated as number of copies NF-YAl/NF-YAs. C. Real-time RT-
PCR analysis of the indicated transcripts in proliferating myoblasts (Mb) and upon differentiation for 0, 2, and 6 days. mRNA levels are indicated as relative expression in differentiated
cells versus proliferating myoblasts (arbitrarily set at 1). Data are mean of four independent experiments ±s.d.
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converted MTT was removed and 1 ml of MTT solvent (4 mM HCl,
0.1% NP-40 in isopropyl alcohol) was added to each well. The plate
was gently rotated on an orbital shaker in the dark for 15 min before
the measurements of absorbance at 570 nm.
2.8. Western blot analysis
Whole cell protein extracts were prepared by cell lysis into 1X SDS
sample buffer (25 mM TrisHCl pH 6.8, 1.5 mM EDTA, 20% glycerol, 2%
SDS, 5% β-mercaptoethanol, 0.0025% Bromophenol blue). For immuno-
blotting, equivalent amounts of cellular extracts were resolved by SDS-
PAGE, electrotransferred to PVDF membrane (GE Healthcare), and
immunoblotted with the following primary antibodies diluted 1:1000in TBS 1X–BSA 1 μg/μl: anti-NF-YA (sc-10779, Santa Cruz), anti-NF-YB
(GeneSpin), anti-MyoD C-20 (sc-304, Santa Cruz), anti-MyHCII MF20
(Developmental Studies Hybridoma Bank, IA, USA), anti-Myogenin M-
225 (sc-304, Santa Cruz), anti-Vinculin (V4504, Sigma Aldrich), anti-
Cyclin B1 (V152) (Gene Tex), and anti-phospho-Histone H3 (Millipore).
Chemiluminescent detection reagent has been purchased from
Millipore (Luminata Classico and Forte Western HRP).2.9. Immunoﬂuorescence staining
Immunoﬂuorescence staining was carried out on C2C12 cells using
anti-MyHCII MF20 (Developmental Studies Hybridoma Bank, IA, USA)
and anti-NF-YA (sc-10779, Santa Cruz) antibodies, as described [40].
Fig. 2. NF-YA knock-down in C2C12 cells affects their proliferation and differentiation. A. Analysis of the expression levels (upper panel) and relative quantiﬁcation (lower panel) versus
Vinculin of NF-YAl, CyclinB1, and H3-PSer10 in control (shCTR) and NF-YA-inactivated (shNF-YA) cells. Data are mean of four independent experiments ±s.d. Right panel: qRT-PCRs
of the indicated transcripts in control and NF-YA knocked-down cells. The bars represent the mean of four independent experiments ±s.d. B. Cytoﬂuorimetric cell cycle analysis of
shCTR and shNF-YA cells. Error bars indicate s.d. of three biological replicates. C. Western blot analysis of NF-YAl and myogenic factors MyoD, Myogenin, and MyHCII in shCTR and
shNF-YA cells induced to differentiate for 3 days.
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Gene expression proﬁlings were performed using Affymetrix tech-
nology on RNA extracted from two biological samples of empty, NF-
YAs and NF-YAl overexpressing cells induced to differentiate for
3 days (C3-DM). Total RNA was puriﬁed using the RNeasy Mini kit
(Qiagen) according to the manufacturer's protocol. Disposable RNA
chips (Agilent RNA 6000 Nano LabChip kit) were used to determine
the concentration and purity/integrity of RNA samples using the Agilent
2100 bioanalyzer. cDNA synthesis, biotin-labeled target synthesis,
Affymetrix GeneChip Mouse 430 2.0 array (Affymetrix, Santa Clara,CA) arrays hybridization, staining, and scanning were performed ac-
cording to the standard protocol supplied by Affymetrix. Probe levels
data were normalized and converted to expression values using the Ro-
bust Multiarray Average (RMA) procedure or the DChip procedure (in-
variant set). Quality control assessment was performed using
Bioconductor packages (R-AffyQC Report, R-Affy-PLM, R-RNA Degrada-
tion Plot) and only arrays passing the quality controlswere processed to
the next step for differential gene expression analysis. Differentially
expressed genes were selected for having a differential fold change
above 2 with respect to the control sample (Empty). Gene Ontology of
up-regulated genes and down-regulated genes were analyzed with
Fig. 3. NF-YAs forced expression in C2C12 stimulates cell proliferation. A. Upper panel:Western blot analysis of NF-YA, CyclinB1, and H3-PSer10 in NF-YAs and NF-YAl overexpressing C2C12
cells, compared to empty cells. Lower panel: quantiﬁcation of CyclinB1 and H3-PSer10 protein levels in NF-YAs/l stably infected cells versus empty cells (arbitrarily set at 1) of three
independent experiments. B. Upper panel: expression levels of NF-YA transcript variants in stably infected C2C12 cells using common primers. Rplp0 was used as internal control.
Lower panel: Analysis of the levels of NF-YA transcripts in C2C12 NF-YAs- and NF-YAl-overexpressing cells compared to endogenous levels (empty cells) by real-time RT-PCRs with
isoform-speciﬁc primers. The bars represent the mean of four independent experiments ±s.d. C. Immunoﬂuorescence analysis of NF-YA expression in empty, NF-YAs, and NF-YAl
C2C12 cells. Nuclei were stained with DAPI. D. MTT cell proliferation assay of NF-YAs and NF-YAl overexpressing cells versus empty cells at the indicated time points from cells
seeding. Data are the mean of six independent experiments ±s.d. E. BrdU/PI cytoﬂuorimetric analysis of empty and NF-YAs/l overexpressing cells 48 and 72 h from cells seeding. Data
are the mean of three independent experiments ±s.d.
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tially expressed gene sets in C2C12 NFYAl cells with respect to C2C12
NFYAs cells. Affymetrix CEL ﬁles were processed with the GenePattern
tool using the rma normalization option. The gct ﬁle was uploaded
into GSEA v1.0 and gene set enrichment analysis was performed using
the gene set database c5.all.v5.1.symbols (Gene Ontology) with the fol-
lowing setting: 1000 permutation, gene-set as permutation type,
weighted as enrichment statistic, ratio of classes as metric for ranking
genes. The GSEA results were ranked according to the nominal p-
value (b0.005) and FDR (≥0.01).2.11. RT-PCRs analysis
RNAwas extracted from C2C12 cells using the Purelink RNAmini kit
(Invitrogen, Life Technology) according to the manufacturer's protocol
and 3 μg of RNA were retro-transcribed with a Moloney murine leuke-
mia virus reverse transcriptase (MMLV-RT) (Promega). Real-time PCRs
were performed with oligonucleotides designed to amplify
100–200 bp fragments: sequences are available upon request. The
housekeeping gene Rplp0 was used as a loading control. The relative
sample enrichment was calculated with the formula 2–(ΔΔCt), where
Fig. 4. NF-YAl overexpression increases differentiation of C2C12 cells. A. Light microscopy
analysis of C2C12 stably infected cells. C = conﬂuent cells, C3-DM = conﬂuent cells
maintained for additional 3 days in differentiating medium. The arrows indicate large
myoﬁbers. Images are representative of ten independent experiments. B. MyHCII
immunoﬂurescence analysis of empty, NF-YAs, and NF-YAl C2C12 cells. The pie chart
represents the percentage of multinucleated myoﬁbers; different colors are indicative of
the number of nuclei per MyHCII-positive myoﬁber. Percentages are the mean of three
independent experiments. C. Western blot analysis of the indicated proteins in C and
C3-DM empty and NF-YAs/l stably infected cells. Images are representative of at least
three independent experiments.
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sample (Empty, NF-YAs, or NF-YAl) and y = Empty proliferant sample.
For generation of the absolute standard curves, cDNA of NF-YAs and
NF-YAl transcripts were obtained by PCR. PCR products were run on a
1% TAE agarose gel. The fragments were excised and eluted using
PromegaWizard®SVGel andPCR Clean-Up System. The concentrations
of the PCR products were measured using Nanodrop 1000. Micrograms
of DNA were then converted to picomoles. Equimolar dilutions of both
PCR fragments were used to generate the standard curves of seven or-
ders of magnitude.
2.12. Chromatin ImmunoPrecipitations (ChIP)
Chromatin immunoprecipitationswere performed as previously de-
scribed [41,42]. 5 μg of anti-NF-YA (sc-10779, Santa Cruz) and anti-NF-
YB (GeneSpin) were added to each IP and incubated over-night at 4 °C
on a rotating wheel. DNAs were resuspended in TE buffer and quantita-
tive real-time PCR was performed using SYBR green reagent
(ThermoFisher) in the LightCycler Roche PCR machine. The relative
sample enrichment was calculated with the following formula:
2ΔCtx − 2ΔCty, where ΔCt x = Ct input − Ct sample and ΔCt y = Ct
input− Ct control Ab. Data have been shown asmeans of four indepen-
dent experiments. Semiquantitative PCRs were performed to amplify
the Cdkn1c promoter with primers described in Ref. [16].
2.13. Statistical analysis
All statistical analyses were performed using GraphPad Prism soft-
ware (GraphPad Software, Inc., La Jolla, CA, USA). One sample t-test
was used for gene expression analysis presented in Figs. 1C, 2A (right
panel), 3B (lower panel), 5B, 6A (left panel), 6D (left panel) and for
Western blot quantiﬁcation analysis shown in Figs. 2A (left panel), 3A,
6A (right panel). One sample t-testwas also performed to analyze trans-
fection and ChiP data of Figs. 6B (right panel), 6C (right panel), and 6D
(middle and right panel). P values of b0.05were considered to be statis-
tically signiﬁcant (*), b0.01 (**), b0.001(***), and b0.0001 (****). Un-
paired t-test (two-tailed) was used for Figs. 2B, 3E, 5C (lower panel),
5D and 6C (middle panel). P values of b0.05 were considered to be sta-
tistically signiﬁcant (*), b0.01 (**), b0.001 (***), and b0.0001 (****). To
compare means across empty and NF-YA-overexpressing cells, in
Fig. 3D, one-way ANOVA analysis was utilized. P values of b0.05 were
considered to be statistically signiﬁcant (*). The number of biological
or technical replicates used for the calculation of themean, s.d. and sta-
tistical analysis was indicated in ﬁgure legends.
3. Results
3.1. NF-YA inactivation impairs cell proliferation and differentiation
To investigate the mechanisms by which NF-YA affects myogenic
progression, we used the mouse C2C12 cell line, immortalized adult
post-injury-derived cells, able to recapitulate the process of adult
myogenesis [43]. These cells were shown to express NF-YAl, whose
levels decrease following differentiation [26] (Fig. 1A). To a lower ex-
tent, however, NF-YAs protein and mRNA are detected in C2C12, and
lost after differentiation (Fig. 1A-C). Absolute quantiﬁcations of NF-
YAs and NF-YAl mRNA levels, based on a standard curve, conﬁrmed
that NF-YAl was the prevalent transcript in proliferating myoblasts,
being about 8.5-fold more abundant than NF-YAs (Fig. 1B).
As expected, differentiated cells showed a drop in the expression of
Myf5 and an increase of MyoD, followed by Myogenin and Myosin
Heavy Chain II (MyHCII) (Fig. 1A). qRT-PCRs highlighted that both NF-
YA isoforms, as well as Myf5, MyoD, Myogenin, and MyHCII, are in
part regulated at the transcriptional level (Fig. 1C). CyclinB1 and
CyclinB2 levels were down-regulated following differentiation, as ex-
pected (Fig. 1C).
Fig. 5. Transcriptional effects of NF-YAs and NF-YAl overexpression in C2C12 cells. A. GeneOntology (GO) terms displaying a statistically signiﬁcant over-representation in the sample-set (up-
and down-regulated genes inNF-YAs andNF-YAl cells versus control cells). P values refer to the over-representation (seeMaterials andmethods). Only GO termswith p b 1.00E−08were
displayed and ranked by decreasing NF-YAl P-value. B. Real-time RT-PCR analysis of the indicated transcripts in C2C12 stably infected cells maintained in differentiating conditions for
3 days (C3-DM).mRNA levels of themean of three biological replicates are indicated as relative expression compared to emptymyoblasts (arbitrarily set at 1). C. Upper panel: semiquan-
titativeRT-PCRanalysis of the splice variants ofNF-YA (s and l) andMef2D (β no-β), and of Cdkn1a in the indicated cell culture conditions. C=conﬂuent cells and C3-DM=conﬂuent cells
maintained for additional 3 days in differentiating medium. Lower panel: Quantiﬁcation of β/no-β ratio and Cdkn1a mRNA levels in stably infected cells. The values of three independent
experiments are indicated as fold change versus empty conﬂuent cells ±s.d. D. ChIP analysis showing NF-YA and NF-YB recruitment to regulatory regions of the indicated genes in C2C12
cells. Values are represented as % of Input DNA ±s.d. Statistical analysis (unpaired t-test) was performed to compare the enrichment of NF-YA/NF-YB versus negative control antibody
(NC). P values b0.01 were considered to be statistically signiﬁcant (⁎⁎), b0.001(⁎⁎⁎), and b0.0001 (⁎⁎⁎⁎).
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ation, we infected C2C12 cells with shRNA lentiviral particles targeting
NF-YA. Fig. 2A shows a signiﬁcant decrease in the protein levels of NF-
YAl, but qRT-PCR indicates that both NF-YA transcripts were down-
regulated by RNAi (Fig. 2B). Also the levels of the NF-Y target genes
CyclinB1 and CyclinB2 were transcriptionally down-regulated upon
NF-YA inactivation, as expected (Fig. 2B). Cell proliferation was affectedby NF-YA loss and an increase in G2/M population, compared to control
cells (shCTR), was observed (Fig. 2A). Indeed, lowered CyclinB1 and
phospho-Ser10H3 (H3-PSer10) levels are consistent with a G2 arrest
(Fig. 2A). Moreover, we induced these cells to differentiate by serum
withdrawal and analyzed the levels of differentiation markers: the ex-
pression of MyoD, Myogenin, and MyHCII were robustly reduced in
shNF-YA with respect to shCTR cells (Fig. 2C).
635V. Basile et al. / Biochimica et Biophysica Acta 1859 (2016) 627–638These data conﬁrm that NF-YA expression is necessary formyoblasts
proliferation and highlight a potential activity of NF-Y in myogenic
differentiation.3.2. Role of NF-YAs and NF-YAl in proliferation of C2C12 cells
To study the activity of NF-YA isoforms in myoblasts proliferation,
we stably overexpressedNF-YAs andNF-YAl in C2C12 cells. Overexpres-
sion and nuclear localization of NF-YA proteins were conﬁrmed by
Western blot, RT-PCRs, and immunostaining (Fig. 3A-C). Note that en-
dogenousNF-YAl decreased in NF-YAs-overexpressing cells both at pro-
tein and mRNA level (Fig. 3A and B).
We then compared the effects of NF-YA forced expressions on prolif-
eration. A signiﬁcant difference was observed from 48 h post-cells
seeding: empty cells reached the plateau phase in 72 h, NF-YAl cells
stopped growing 1 day before control cells, while NF-YAs cells contin-
ued proliferating even in conﬂuence (Fig. 3D). The increase of the prolif-
eration markers CyclinB1 and H3-PSer10 corroborated NF-YAs positive
effect on cell growth (Fig. 3A).
PI/BrdU biparametric cell cycle cytoﬂuorimetric analysis was per-
formed on C2C12 myoblasts 48 and 72 h after seeding (Fig. 3E). Com-
pared to control cells, at 48 h NF-YAs cells did show an increase of
about 30% of BrdU positive cells, and a reduction of G0/G1 events. In
contrast, NF-YAl induced a 20% decrease in the proportion of S phase
cells and a 10% increase in G0/G1 events. At 72 h, the effect of NF-YAs
on DNA replication was even more evident, as BrdU incorporating
cells increased from 3% to 16%, further suggesting that NF-YAs signiﬁ-
cantly stimulates cell proliferation.3.3. NF-YAl overexpression increases myogenic differentiation of C2C12
cells
We then analyzed the effects of NF-YA isoforms overexpression on
C2C12 differentiation. Light microscopy analysis did not show differ-
ences between empty, NF-YAs, and NF-YAl in cells reaching conﬂuence
(C). On the other hand, in conﬂuent cells maintained for additional
3 days in differentiation medium (C3-DM), NF-YAs cells showed a de-
crease in myotubes formation compared to control cells, while NF-YAl
overexpression generated multiple and large myoﬁbers, hinting that
NF-YAl could stimulate cell differentiation (Fig. 4A). To validate this hy-
pothesis, we immunostained C3-DM cells with anti-MyHCII antibody:
NF-YAl overexpression led to large multinucleatedMyHCII+myotubes
and increased the number of nuclei per myoﬁber; on the contrary, NF-
YAs forced expression led to the formation of few MyHCII+ myotubes,
the majority of which were mononucleated (Fig. 4B). In accordance
with themorphology, higher levels ofMef2D,MyoD,Myogenin,MyHCII,
and MCK were observed byWestern blot in C3-DM NF-YAl-cells, and a
decreasewas detected in NF-YAs-cells (Fig. 4C). Note that an increase of
MyoD expression was detected already in NF-YAl conﬂuent cells (C),
hinting that this isoform could be a positive regulator of MyoD or
could induce early differentiation in conﬂuent cells. In summary, over-
expression of the two NF-YA isoforms leads to a remarkable difference
in the behavior of differentiating myoblasts.Fig. 6. NF-YAs and NF-YAl differently regulate CdnKn1C transcription. A. Left panel: qRT-PCR
differentiated (C3-DM) cells. The bars represent the mean of four experiments ±s.d. Mid
overexpressing cells compared to empty cells. Protein levels of control cells have been arb
alignment of Cdkn1C human and mouse promoters. Conserved CCAAT elements have been fr
Cdkn1c-LUC vector with 100 ng NF-YAs and NF-YAl expressing plasmids. Data represent
transfection). C. Left panel: ChIP analysis of NF-Y binding to the Cdkn1C promoter in
immunoprecipitated with the NF-YB antibody versus negative control antibody (NC) and ar
panel: relative enrichment of NF-Y binding to the Cdkn1C promoter in NF-YA-overexpre
independent experiments with ﬁve technical replicates ± s.d. D. Left panel: qRT-PCR of Kcnq
of empty cells have been arbitrarily set at 1 and the values are the mean of three experiment
NF-YAl transient overexpression. The bars represent the mean of three technical replicates
empty, NF-YAs and NF-YAl conﬂuent cells. Relative enrichment of NF-Y binding to the Kcnq1o
set at 1). NC = negative control antibody. Data are the mean of three experiments.3.4. NF-YAs and NF-YAl differentially regulate the transcriptional program
governing skeletal myogenesis
To gain insight into the role of NF-YA isoforms duringmuscle differ-
entiation, we performed gene expression proﬁlings of C2C12 stably
overexpressing the two isoforms, induced to differentiate for 3 days
(C3-DM). We found that 799 and 476 genes were differentially regulat-
ed (with fold change ≥2.0) in NF-YAs and NF-YAl cells, compared to
empty cells. Speciﬁcally, 374 and 210 genes were down-regulated,
425 and 266 genes were up-regulated in NF-YAs and NF-YAl-cells, re-
spectively. Remarkably, Gene Ontology (GO) analysis highlighted that
NF-YAs down-regulated categories were a nearly perfect mirror of NF-
YAl up-regulated terms, and vice versa (Fig. 5A). GO terms associated
tomuscle structure and function, speciﬁcally contractile ﬁber, myoﬁbril,
contractile ﬁber part, sarcomere, I band, Z disc, sarcoplasmic reticulum/
sarcoplasm are up-regulated by NF-YAl and repressed by NF-YAs. Dif-
ferently, NF-YAs up-regulated categories were mainly associated to
growth-factor binding and extracellular proteins, mostly down-
regulated in the NF-YAl cohort. Gene set enrichment analysis (GSEA)
comparing NF-YAl with respect to NF-YAs expression data highlighted
that gene sets associated to muscle structure and function were signiﬁ-
cantly up-regulated in NF-YAl cells compared to NF-YAs cells, in agree-
mentwith GO analysis and phenotypic differences between the twoNF-
YA-overexpressing cell lines (Suppl. Table 1).
Real-Time RT-PCRs on empty-, NF-YAs-, and NF-YAl cells were per-
formed to validate the microarray data (Fig. 5B). A ﬁrst group includes
genes up-regulated by NF-YAl and down-regulated by NF-YAs, such as
MyoD, Myogenin, and CyclinD3, key players in early cell differentiation,
and MCK, marker of late differentiation. We also analyzed the expres-
sion of Six genes, which cooperatewithMRFs in themyogenesis regula-
tory network [5]. The mRNA levels of Six1 and Six4, both required for
myoblast differentiation, were doubled by NF-YAl and halved by NF-
YAs (Fig. 5B).
A second group consists of genes affected mostly by a speciﬁc iso-
form, such as Igf1, Tgfbi, Mef2C, Mef2D, Cdkn1a, Igf2, Kitl, and Figf. In
particular, Cdkn1a, Mef2C, and Mef2D transcripts were up-regulated
only upon NF-YAl overexpression (Fig. 5B and C). Transcripts of the
Mef2 family are subject to alternative splicing, which can affect their ac-
tivation potential: inclusion of the β-exon occurs during muscle differ-
entiation and leads to a more robust activation of Mef2-target genes
[44]. The increase of the Mef2D β/no-β ratio was indeed enhanced by
NF-YAl overexpression in differentiation conditions (C3-DM) (Fig. 5C).
A third group is composed of genes up-regulated by NF-YAs and
down-regulated by NF-YAl, such as Six5, Bmp4, Wisp2, and Htra1.
We then analyzed the genes for the presence of TFBS (Transcription
Factors Binding Sites) in their promoters, using PSCAN and the JASPAR
database (Suppl. Fig.1): many matrices were present in the activated
and repressed cohorts analyzed—particularly E2Fs, GC-rich KLFs, Sp1/
2, and TPAP2—with similar p values, making it unlikely that these tran-
scription factors are involved in differential regulation. Surprisingly, the
CCAAT boxmatrixwas not enriched, suggesting that NF-YA overexpres-
sion might not affect the mRNA levels of the majority of differentially
expressed genes through binding to the promoters and direct transcrip-
tional regulation. Instead, MRF matrices (MyoD, Myogenin) wereof Cdkn1C transcript in empty, NF-YAl- and NF-YAs-overexpressing conﬂuent (C) or
dle and right panels: protein levels and relative quantiﬁcation of p57kip2 in NF-YA-
itrarily set at 1 and the bars indicate the mean of ﬁve values. B. Left panel. Sequence
amed. Right panel: relative luciferase activity following transient co-transfections of the
means ± s.e.m. of three independent transfections (two technical replicates for each
C2C12 conﬂuent cells. Middle panel: the bars indicate fold enrichment of NF-Y
e the mean of three technical replicates of three independent experiments ± s.d. Right
ssing cells compared to empty cells (arbitrarily set at 1). Data are the mean of two
1ot1 transcript in empty and NF-YA-overexpressing conﬂuent cells (C). Transcript levels
s ± s.d. Middle panel: Kcnq1ot1 promoter-driven luciferase activity following NF-YAs or
of three different transfections ± s.e.m. Right panel: qChIP analysis of NF-Y binding in
t1 promoter in NF-YA-overexpressing cells has been compared to empty cells (arbitrarily
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in keeping with the observed morphological effect. This result suggests
that, at least in part, the NF-YAl effect could be due to increased expres-
sion of myogenic transcription factors, which could then initiate the
muscle-speciﬁc gene programs. The regulatory regions of MyoD,
Mef2C, Mef2D, and Six genes indeed contain one or more CCAAT ele-
ments. ChIP analysis showed NF-Y binding to Mef2D and Six regulatory
regions, but not toMef2C orMyoD promoters (Fig. 5D). The promoter of
CyclinB2, a known NF-Y target gene, was used as positive control, while
the CCAAT-less Myogenin was used as negative control.
In summary, speciﬁc changes in C2C12 differentiation programs are
affected by the NF-YA isoforms, mostly, but not necessarily exclusively,
through an impact in some of the muscle-speciﬁc transcription factors.
3.5. Cdkn1c is a novel NF-Y-regulated target gene
Among genes up-regulated by NF-YAl and down-regulated by NF-
YAs, Cdkn1c is particularly relevant, because of its dominant role in
pushing differentiation. qRT-PCR andWestern blot conﬁrmed the differ-
ent effect on gene expression in NF-YA stable-expressing cells (Fig. 6A).
Three conserved CCAAT elements are located within the core promoter
of the murine and human gene (Fig. 6B); we decided to investigate
whether the two NF-YA isoforms could differently affect Cdkn1c tran-
scription. Transient co-transfections of a Cdkn1c-LUC vector with NF-
YAs and NF-YAl plasmids showed a robust increase in activity, equally
induced by the two isoforms (Fig. 6B). This could be dissimilar in vivo,
where the promoters are assembled into chromatin: we therefore per-
formed ChIP analysis of NF-Y binding in C2C12 control and NF-YA over-
expressing cells. NF-Y was clearly associated to the promoter of Cdkn1c
in conﬂuent C2C12 (Fig. 6C, left and middle panel), and an enrichment
in binding is observed in NF-YAl cells compared to empty and NF-YAs
(Fig. 6C, right panel), reﬂecting the increased transcription levels ob-
served with former isoform (Fig. 6A).
Cdkn1c transcription is regulated by the lncRNAKcnq1ot1. In partic-
ular, increased Kcnq1ot1 levels are associated to reduced p57kip2 ex-
pression and NF-Y binding was demonstrated to be important for the
regulation of Kcnq1ot1. We investigated the effects of NF-YAs and NF-
YAl overexpression on this transcript: qRT-PCRs showed a signiﬁcant
decrease in Kcnq1ot1 RNA levels in conﬂuent shNF-YAl cells, consistent
with increased Cdkn1c transcription (Fig. 6D, left panel). The two splice
variants did not showdifferences in activation of a Luciferase reporter in
transfection assays (Fig. 6D, middle panel), but again, ChIP analysis
showed lower NF-Y binding to the Kcnq1ot1 promoter only in NF-YAl
overexpressing cells (Fig. 6D, right panel).
All together, these results provide evidence that NF-Y controls an
important pro-differentiation gene via a lncRNA, hinting at a differential
behavior of NF-YAs and NF-YAl in vivo, with diverse effects on speciﬁc
CCAAT promoters.
4. Discussion
We report on the dual function of the transcription factor NF-Y in the
regulation of proliferation and differentiation of skeletal muscle cells.
Opposite activities are played by the two NF-YA splice variants, which
activate different transcriptional and cell fate programs. These data are
consistent with previous reports in HSCs and mouse mESCs showing
that NF-YAs is the splice variant with pro-proliferative activity [31,34].
We describe here a novel role for NF-YAl to favor the commitment to
differentiation of myoblasts.
We overexpressed NF-YA isoforms in C2C12 immortalized myo-
blasts, in which NF-YAl is the major variant: forced expression of NF-
YAs results in increased proliferation, while higher levels of NF-YAl
stimulate myoblasts fusion into large multinucleated myotubes. These
results conﬁrm NF-YAl modulation during C2C12 differentiation [26]
and show a novel positive role in muscle differentiation, which was un-
noticed before. Previous experiments performed in C2C12 through NF-YAl transient overexpression showed that NF-YA down-regulation al-
lows cells to exit the cell cycle and induces terminal differentiation pro-
gram [26]. The different technical approaches used in our present work
and in previous studies [26] likely account for the differences in the ob-
tained results: stable infection of C2C12 cells shows moderate increase
in protein levels compared to control cells, whereas transfections with
NF-YAl considerably, but transiently, raise its expression [26]. Thus, it
is possible that “chronic” versus “acute” overexpression of NF-YAl
could activate different molecular and phenotypic effects. Note that
myogenic conversion experiments by transient overexpression show
that both NF-YA isoforms interfere with the myogenic program (data
not shown), suggesting that not only the levels but also the timing of
NF-YA overexpression is important for muscle differentiation.
The functional difference between the two NF-YA isoforms, present-
ed for theﬁrst time here, is striking. Since its original discovery [45], dif-
ferent sets of data relegated the issue of NF-YA splicing into an oblivion:
(i) various balanced levels of NF-YAl/NF-YAs are present in different cell
types, with little apparent logic; (ii) the DNA binding afﬁnity of trimers
composed of NF-YAs or NF-YAl are similar in vitro; (iii) the spliced do-
main doesn't show signiﬁcant differences in the aminoacids
composition—high Q and hydrophobics content—with respect to the
large N-term activation domain where it resides [35–37,46], which is
reﬂected in a similar trans-activating behavior, at least in artiﬁcial acti-
vation assays. It is now clear that they are part of different, even oppo-
site, transcriptional programs. In addition, our ﬁndings might also bear
implications on the splicing of NF-YC, since there is a good correlation
between NF-YAs and NF-YC-50, and between NF-YAl and NF-YC-37, at
least in the cell lines tested so far [46].
NF-Y is a pioneer factor [47–49], known to activate the genes of
many “activator/effector” transcription factors responsible for switching
on speciﬁc transcriptional pathways. In most cases, the speciﬁc activa-
tor/effector protein teams up with NF-Y to jointly activate genes of
that pathway: it is the case of SREBP1/2 (cholesterol/fatty acids), HSF1
(heat shock), CHOP and XBP1 (ER stress), E2F1 (cell cycle) [50]. These
factors require the pioneering role of NF-Y in pre-setting the chromatin
state of the targeted promoters before activation. Because of the tran-
scriptional effects of NF-YAl overexpression, obvious activator tran-
scription factors candidates for the pro-differentiation effects were
MyoD, which harbors a perfect CCAAT in the promoter, and Myogenin.
However, ChIPs were negative, proving that the effect on these genes
is indirect. Instead, direct NF-Y binding is observed on the genes of
two other transcription factors important in muscle differentiation,
Mef2D and Six family members. The analysis of ENCODE genome-
wide locations of Mef2A/C in several cell lines indicates a lack of inter-
sections with NF-Y [47] (DD, RM, G. Pavesi, submitted). Unless Mef2
proteins bind to substantially different sets of genes in muscle cells,
we consider a global synergistic effect of NF-Y onMef2 unlikely. Rather,
because members of the Mef2 family are known to activate MyoD and
Myogenin, we favor a scenario in which NF-YAl triggers a CCAAT-less
genes program mediated by Mef2D, and, subsequently, MyoD and
Myogenin. Note that Mef2D, but not Mef2C, is targeted: although func-
tional redundancy was described within Mef2 family members, this
suggests that different mechanisms are involved in the control of
Mef2 genes expression. NF-YAl ectopic expression not only increases
Mef2D gene expression but also modulates its splicing pattern.
As for the homeobox-containing Six family members, Six1/4/5 are
important for muscle differentiation [5,51,52]: they share the same
binding consensus and directly control the expression of Myogenin via
MEF3 sites, both in cultured cells and in vivo [9,53]. Direct NF-Y binding
to the promoters and activation of Six genes upon NF-YAl overexpres-
sion points to a second branch of “differentiation” genes activated by
the latters. Interestingly, CCAAT boxes are enriched in Six5 peaks of
ENCODE data, with a very robust overlap of nearby peaks in different
cell lines (DD, RM, G. Pavesi, submitted). Six5 peaks are heavily enriched
in binding sites of Znf143 [54], an important cell cycle regulator [55],
which are also found near NF-Y. Thus, it is possible that NF-Y and Six
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tions. This hypothesis is worth validating with genomic studies in the
future.
Among genes directly regulated by NF-Y, we identiﬁed Cdkn1c,
encoding for the CDKI p57kip2. Differently from p21Cip1/Waf1, which par-
ticipates tomyogenesis only through cell growth arrest, p57kip2 has also
an active role in supporting MyoD function [56,57]. Following NF-YAl
overexpression, NF-Y increases p57kip2 levels through a double mecha-
nism: in physiological chromatin context, it binds and up-regulates the
Cdkn1c CCAAT promoter, and, at the same time, reduces its association
to the regulatory region of Kcnq1ot1, whose expression is therefore re-
versely correlated with the expression of Cdkn1c. These data hint that
the composition of the NF-Y heterotrimer could affect the hierarchy of
target genes, with a selection exerted through the different splice vari-
ants of the CCAAT-binding subunit. This hierarchy could reﬂect the op-
posite role played by NF-YAs and NF-YAl, with NF-YAs binding to genes
promoting cell proliferation or inhibiting cell differentiation (such as
Kcnq1ot1), and NF-YAl favoring NF-Y recruitment to genes that arrest
cell cycle progression (among which Cdkn1C) or participate to the dif-
ferentiation program (such as Mef2D, Six1, and Six4). In addition, the
two NF-YA isoforms could initiate different transcriptional programs
because of speciﬁc combinatorial efﬁciencies in protein–protein interac-
tions of the Q-rich activation domain: when NF-YAs and NF-YAl are
bound to CCAAT, different coactivator complexes could be associated
through speciﬁc interactions with the isoforms, triggering diverse tran-
scriptional and physiological responses. This matter should be thor-
oughly evaluated in the future, by developing appropriate reagents,
such as isoforms-speciﬁc antibodies and shRNAs.
5. Conclusions
In conclusion, we demonstrated that post-transcriptional regulation
of NF-YA expression is important in determining myoblasts fate and
provides evidence of the role of alternative splicing in proliferation ver-
sus differentiation programs. Our data corroborated the pro-
proliferative activity of NF-YAs and identiﬁed a different, not previously
appreciated, role for NF-YAl in favoring the commitment to
differentiation.
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